Article
27 Oct 2025
FDA Regulatory Approval Updates
AUTHORS CONTENT
Article
19 Aug 2025
Genentech Files First Pertuzumab BPCIA Complaint Against Shanghai Henlius And Organon
Article
01 Aug 2025
Biocon Regulatory Approval Updates In The U.S. And Europe: Insulin Aspart And Denosumab
Article
06 May 2025
Update On Regeneron's Supplemental BLA For EYLEA HD
Article
08 Apr 2025
Global Biosimilar Updates – Spring 2025
Article
09 Jan 2025
FDA Approves Celltrion's STEQEYMA (Ustekinumab-stba)
Article
29 Nov 2024
European Commission Approves Samsung Bioepis And Biogen's Aflibercept Biosimilar
Article
28 Oct 2024
Accord Biopharma Announces FDA Approval Of IMULDOSA (Ustekinumab-srlf)
Article
25 Sep 2024
Eli Lilly Files Suit Challenging The FDA's Drug Classification Of Retatrutide
Article
21 Aug 2024
FDA Seeks Input On Biosimilar Product Development Guidance
Article
10 Jun 2024
FDA Approves Moderna's MRESVIA Vaccine
Article
07 Jun 2024
FDA Launches Support For Clinical Trials Advancing Rare Disease Therapeutics (START) Pilot Program
Article
09 May 2024
FDA Updates Draft Guidance On Promotional Communications Of Prescription Biologics And Biosimilars
Article
05 Mar 2024
Alvotech Announces More Settlements And Expected Launch Dates Regarding Biosimilar To STELARA (Ustekinumab), AVT04
Article
30 Jan 2024
Alvotech And STADA Obtain Approval In Europe For Ustekinumab Biosimilar, UZPRUVO